Amantadine
- Product NDC
- 67046-1531
- 11-digit product format
- 670461531
- Labeler code
- 67046
- Product ID
- 67046-1531_303c5b22-0edf-b2d7-e063-6394a90a9de6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA214284
- Marketing category
- ANDA
- Marketing start
- 2025-03-13
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| M6Q1EO9TD0 | AMANTADINE HYDROCHLORIDE | 665-66-7 | AMANTADINE HYDROCHLORIDE |
| BF4C9Z1J53 | AMANTADINE | 768-94-5 | Amantadine |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67046-1531-3 | 67046153103 | 30 TABLET in 1 BLISTER PACK (67046-1531-3) | 30 tablet | 2025-03-13 | No | No | Historical |